SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,218,336 | -60.1% | 59,200 | -8.8% | 0.00% | -50.0% |
| Q2 2023 | $3,050,658 | +9.5% | 64,880 | -2.3% | 0.00% | 0.0% |
| Q1 2023 | $2,786,983 | +8.5% | 66,420 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $2,568,081 | -1.1% | 67,333 | +1.5% | 0.00% | 0.0% |
| Q3 2022 | $2,597,000 | +19.3% | 66,312 | -1.6% | 0.00% | +33.3% |
| Q2 2022 | $2,176,000 | -2.3% | 67,370 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $2,227,000 | -28.3% | 67,281 | -7.8% | 0.00% | -25.0% |
| Q4 2021 | $3,105,000 | -19.8% | 72,998 | -16.4% | 0.00% | -20.0% |
| Q3 2021 | $3,871,000 | -22.1% | 87,370 | -0.1% | 0.01% | -16.7% |
| Q2 2021 | $4,968,000 | -25.6% | 87,447 | -2.0% | 0.01% | -33.3% |
| Q1 2021 | $6,681,000 | -13.6% | 89,253 | -0.2% | 0.01% | -18.2% |
| Q4 2020 | $7,737,000 | +43.6% | 89,438 | +1.5% | 0.01% | +22.2% |
| Q3 2020 | $5,387,000 | +49.4% | 88,132 | +1.6% | 0.01% | +50.0% |
| Q2 2020 | $3,605,000 | +44.7% | 86,711 | -0.0% | 0.01% | +20.0% |
| Q1 2020 | $2,491,000 | -61.2% | 86,724 | -2.6% | 0.01% | -54.5% |
| Q4 2019 | $6,425,000 | -43.6% | 89,008 | +9.6% | 0.01% | -50.0% |
| Q3 2019 | $11,393,000 | -22.4% | 81,209 | +1.2% | 0.02% | -24.1% |
| Q2 2019 | $14,691,000 | +19.9% | 80,240 | +4.1% | 0.03% | +16.0% |
| Q1 2019 | $12,254,000 | +78.8% | 77,043 | +7.7% | 0.02% | +56.2% |
| Q4 2018 | $6,852,000 | -30.6% | 71,529 | +2.3% | 0.02% | -15.8% |
| Q3 2018 | $9,875,000 | -9.8% | 69,915 | -0.0% | 0.02% | -17.4% |
| Q2 2018 | $10,948,000 | +6.0% | 69,940 | +9.0% | 0.02% | +4.5% |
| Q1 2018 | $10,332,000 | +5.2% | 64,147 | +7.6% | 0.02% | +10.0% |
| Q4 2017 | $9,822,000 | +184.9% | 59,635 | +7.8% | 0.02% | +150.0% |
| Q3 2017 | $3,447,000 | -29.3% | 55,329 | -9.7% | 0.01% | -20.0% |
| Q2 2017 | $4,878,000 | +15.7% | 61,252 | +3.2% | 0.01% | +11.1% |
| Q1 2017 | $4,217,000 | +32.9% | 59,342 | -4.5% | 0.01% | +50.0% |
| Q4 2016 | $3,173,000 | +7.9% | 62,142 | -2.7% | 0.01% | 0.0% |
| Q3 2016 | $2,940,000 | +75.7% | 63,842 | +14.9% | 0.01% | +50.0% |
| Q2 2016 | $1,673,000 | +58.1% | 55,542 | +68.3% | 0.00% | +100.0% |
| Q1 2016 | $1,058,000 | -29.0% | 33,011 | +29.1% | 0.00% | -50.0% |
| Q4 2015 | $1,491,000 | +39.9% | 25,578 | +1.6% | 0.00% | +33.3% |
| Q3 2015 | $1,066,000 | -42.0% | 25,178 | 0.0% | 0.00% | -25.0% |
| Q2 2015 | $1,838,000 | +246.8% | 25,178 | +138.8% | 0.00% | +300.0% |
| Q1 2015 | $530,000 | +35.9% | 10,545 | -0.9% | 0.00% | 0.0% |
| Q4 2014 | $390,000 | +16.8% | 10,645 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $334,000 | – | 10,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |